Jing Wang

ORCID: 0009-0006-0645-7898
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Immune Cell Function and Interaction
  • Cancer Immunotherapy and Biomarkers
  • Inflammatory Biomarkers in Disease Prognosis
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Radiomics and Machine Learning in Medical Imaging
  • CAR-T cell therapy research
  • Hepatocellular Carcinoma Treatment and Prognosis

Chinese PLA General Hospital
2023-2025

The predictive value of the neutrophil-to-lymphocyte ratio (NLR) for immune checkpoint inhibitors (ICIs) in various tumors remains uncertain despite its use forecasting effectiveness immunotherapy. purpose our research was to determine prognostic significance NLR inhibitor-related myocarditis non-small-cell lung cancer (NSCLC) patients. We enrolled and monitored patients with NSCLC who received ICI therapy at Fifth Medical Center Chinese PLA General Hospital between January 1, 2018, February...

10.1002/cai2.163 article EN cc-by Cancer Innovation 2025-02-20

ABSTRACT Background Colorectal liver metastasis (CRLM) has a poor prognosis, and traditional prognostic models have certain limitations in clinical application. This study aims to evaluate the value of CT‐based habitat analysis CRLM patients compare it with existing provide more evidence for individualized treatment patients. Methods retrospective included 197 whose preoperative contrast‐enhanced CT images corresponding DICOM Segmentation Objects (DSOs) were obtained from The Cancer Imaging...

10.1002/cai2.70000 article EN cc-by Cancer Innovation 2025-03-12
Coming Soon ...